The new anti-Covid vaccine is unique to a dose

Avid-19's vaccine, developed by Jansen, is 66 percent efficient, the Belgian company has announced. In an international test conducted by just one dose of the vaccine, it makes it obviously easier to circulate vaccines than those that require two doses. The United Kingdom has already pre-possed 30 million doses, [...]
In an international test conducted by just one dose of the vaccine, it makes it obviously easier to circulate vaccines than those that require two doses.
The United Kingdom has already pre-possed 30 million doses, Writes BBC, translates Periscope.
This news came shortly after Novavax announced their dose was 89% efficiency. Both should be reviewed by regulators before used.
Jansen, a pharmaceutical company owned by Johnson&Johnson, is investigating whether giving two doses will offer stronger or longer protection.
The company said that initial findings showed that one dose prevented 85 percent of serious cases. /Periscope











